Saturday, September 16, 2017 - 11:20am - 11:50am
Yi-Hsiang Hsu (Harvard Medical School)
The fast moving of the cancer immunotherapy field has generated tremendous excitement regarding new therapeutic strategies and will likely change the paradigm of therapeutic interventions for cancer. Neoantigens, generated by tumor-specific DNA alterations that result in the formation of novel protein sequences and only in cancer cells, represent an optimal target for the immune system and make possible a new class of highly personalized vaccines with the potential for significant efficacy with reduced side effects.
Tuesday, April 21, 2015 - 11:30am - 12:30pm
Viktoria Averina (Boston Scientific), Jeff Sachs (Merck & Co., Inc.)
Viktoria Averina: Algorithm Development for Medical Devices

Implantable cardiac devices such as pacemakers and defibrillators can track and analyze patient’s physiological data. I will showcase key steps of research and development of device-based respiratory monitoring: how one measures patient’s respiratory function, why one would want to track it, and what challenges come up during the implementation.
Subscribe to RSS - Oncology